Atossa Therapeutics Inc (NAS:ATOS)
$ 1.315 -0.005 (-0.38%) Market Cap: 165.37 Mil Enterprise Value: 82.04 Mil PE Ratio: 0 PB Ratio: 1.93 GF Score: 40/100

Atossa Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 28, 2023 / 01:10PM GMT
Release Date Price: $0.755 (-1.69%)
Carvey Leung
Cantor Fitzgerald - Analyst

Good morning, everyone. My name is Carvey, a research associate here at Cantor. Thank you for joining us for a fireside chat. We have Atosis (sic - Atossa). Steve, can you introduce yourself?

Steven Quay
Atossa Therapeutics, Inc. - Chairman and CEO

Yeah. So I am Steven Quay. I'm the CEO and Founder of Atossa Therapeutics.

Questions & Answers

Carvey Leung
Cantor Fitzgerald - Analyst

Awesome. To start, what is your company's strategic vision? Where is the company now, and where do you want it to be in three to five years?

Steven Quay
Atossa Therapeutics, Inc. - Chairman and CEO

So Atossa, Princess Atossa, was the first woman in recorded history with breast cancer, 454 B.C. She was the wife of Darius the Great. And her cancer was treated by cauterizing it; didn't do very well. But we're dedicated from the very beginning with treating breast cancer and breast conditions.

So we are looking at the entire spectrum

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot